TIDIACIC

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7230954 | https://www.ncbi.nlm.nih.gov/pubmed/2262021 | https://www.ncbi.nlm.nih.gov/pubmed/529858 | https://www.drugs.com/international/tidiacic.html

Tidiacic (thiazolidine-2,4-dicarboxylic acid) is a hepatoprotective drug that acts as an antioxidant and a sulfur donor. Tidiacic is a component of tidiacic arginine that used in France for the treatment of toxic liver damage

Approval Year

PubMed

PubMed

Title	Date	PubMed
[Value of the use of a new hepatotropic drug, arginine tidiacicate in gastroenterology. Results of a multicentric study].	1981	7230954

Patents

Patents

Substance Class	Mixture Created by `admin` on `Fri Dec 15 15:35:28 GMT 2023` Edited by `admin` on `Fri Dec 15 15:35:28 GMT 2023`
Record UNII	F39KSS6R80
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TIDIACIC

Official Name

English

TIDIACIC ACID

Common Name

English

TDCA

Common Name

English

Tidiacic [WHO-DD]

Common Name

English

tidiacic [INN]

Common Name

English

2,4-THIAZOLIDINEDICARBOXYLIC ACID

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C2081

Created by admin on Fri Dec 15 15:35:28 GMT 2023 , Edited by admin on Fri Dec 15 15:35:28 GMT 2023

Code System Code Type Description

WIKIPEDIA

TIDIACIC

Created by admin on Fri Dec 15 15:35:28 GMT 2023 , Edited by admin on Fri Dec 15 15:35:28 GMT 2023

PRIMARY

INN

3552

Created by admin on Fri Dec 15 15:35:28 GMT 2023 , Edited by admin on Fri Dec 15 15:35:28 GMT 2023

PRIMARY

MESH

C024158

Created by admin on Fri Dec 15 15:35:28 GMT 2023 , Edited by admin on Fri Dec 15 15:35:28 GMT 2023

PRIMARY

CAS

30097-06-4

Created by admin on Fri Dec 15 15:35:28 GMT 2023 , Edited by admin on Fri Dec 15 15:35:28 GMT 2023

PRIMARY

NCI_THESAURUS

C76667

Created by admin on Fri Dec 15 15:35:28 GMT 2023 , Edited by admin on Fri Dec 15 15:35:28 GMT 2023

PRIMARY

EVMPD

SUB11030MIG

Created by admin on Fri Dec 15 15:35:28 GMT 2023 , Edited by admin on Fri Dec 15 15:35:28 GMT 2023

PRIMARY

DRUG CENTRAL

2659

Created by admin on Fri Dec 15 15:35:28 GMT 2023 , Edited by admin on Fri Dec 15 15:35:28 GMT 2023

PRIMARY

ChEMBL

CHEMBL2064047

Created by admin on Fri Dec 15 15:35:28 GMT 2023 , Edited by admin on Fri Dec 15 15:35:28 GMT 2023

PRIMARY

FDA UNII

F39KSS6R80

Created by admin on Fri Dec 15 15:35:28 GMT 2023 , Edited by admin on Fri Dec 15 15:35:28 GMT 2023

PRIMARY

EPA CompTox

DTXSID30865528

Created by admin on Fri Dec 15 15:35:28 GMT 2023 , Edited by admin on Fri Dec 15 15:35:28 GMT 2023

PRIMARY

ECHA (EC/EINECS)

250-048-3

Created by admin on Fri Dec 15 15:35:28 GMT 2023 , Edited by admin on Fri Dec 15 15:35:28 GMT 2023

PRIMARY

All of the following components must be present:


					390HVB40WZ

TIDIACIC, TRANS-


					VZ2JL0TI2D

Related Record Type Details


					A9539XWW0P

TIDIACIC ARGININE

SALT/SOLVATE -> PARENT

Related Record Type Details


					F39KSS6R80

TIDIACIC

ACTIVE MOIETY

Definition References